Mangoceuticals, Inc. MGRX
We take great care to ensure that the data presented and summarized in this overview for MANGOCEUTICALS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in MGRX
Top Purchases
Top Sells
About MGRX
Insider Transactions at MGRX
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 10
2025
|
Jacob D. Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+50.0%
|
-
|
|
Apr 10
2025
|
Lorraine Pamela D'Alessio Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.54%
|
-
|
|
Apr 10
2025
|
Antonios Isaac President |
BUY
Grant, award, or other acquisition
|
Direct |
60,000
+50.0%
|
-
|
|
Apr 10
2025
|
Alex P. Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+46.87%
|
-
|
|
Apr 10
2025
|
Kenny Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+40.54%
|
-
|
|
Nov 11
2024
|
Eugene M Johnston Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+39.47%
|
-
|
|
Aug 26
2024
|
Jacob D. Cohen Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
800,000
+8.1%
|
-
|
|
Aug 26
2024
|
Jacob D. Cohen Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
800,000
-100.0%
|
-
|
|
Jun 26
2024
|
Alex P. Hamilton Director |
SELL
Open market or private sale
|
Direct |
108,426
-68.44%
|
$0
$0.32 P/Share
|
|
Jun 25
2024
|
Alex P. Hamilton Director |
SELL
Open market or private sale
|
Direct |
16,574
-9.47%
|
$0
$0.31 P/Share
|
|
Jun 03
2024
|
Lorraine Pamela D'Alessio Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+36.36%
|
-
|
|
Jun 03
2024
|
Jacob D. Cohen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
800,000
+50.0%
|
-
|
|
Jun 03
2024
|
Kenny Myers Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+36.36%
|
-
|
|
Jun 03
2024
|
Alex P. Hamilton Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+36.36%
|
-
|
|
Jun 03
2024
|
Amanda Elizabeth Hammer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+36.36%
|
-
|
|
Oct 03
2023
|
Eugene M Johnston Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+20.0%
|
-
|
|
May 01
2023
|
Amanda Elizabeth Hammer Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,000
+50.0%
|
-
|
|
Apr 10
2023
|
Jacob D. Cohen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
275,000
+3.22%
|
$275,000
$1.0 P/Share
|
|
Apr 04
2023
|
Jacob D. Cohen Chief Executive Officer |
BUY
Bona fide gift
|
Direct |
8,000,000
+50.0%
|
-
|
|
Apr 04
2023
|
Jacob D. Cohen Chief Executive Officer |
SELL
Bona fide gift
|
Indirect |
8,000,000
-100.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
1.16M
Shares
From
7
Insiders
| Grant, award, or other acquisition | 360K shares |
|---|---|
| Bona fide gift | 800K shares |
Sell / Disposition
908K
Shares
From
2
Insiders
| Bona fide gift | 800K shares |
|---|---|
| Open market or private sale | 108K shares |